Roche’s Avastin Misses Prostate-Cancer Goal – Wall Street Journal
 Insciences Organisation |
Roche's Avastin Misses Prostate-Cancer Goal
Wall Street Journal ZURICH—Roche Holding AG said Friday its best-selling cancer drug Avastin failed in a late-stage prostate cancer trial, undermining market … Roche's Avastin fails in prostate cancer study Roche: prostate cancer study didn't meet objective Roche Needs Boost After Avastin Fails In Prostate Cancer Trial |
